September 7th 2024
Collaboration between technology providers and biopharma manufacturers are enabling both evolutionary and novel developments.
Lilly to Invest $72 Million for Insulin Manufacturing Upgrade
October 23rd 2017The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
Precipitation as an Alternative to Chromatography in the Insulin Manufacturing Process
The authors explore the use of precipitation using polyvinyl sulfonic acid and zinc chloride in place of capture chromatography to reduce the cost of goods in the insulin manufacturing process.